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Objective. Sublingual microcirculatory alterations are associated with an adverse prognosis in several critical illness subgroups.
Up to now, single-center studies have reported on sublingual microcirculatory alterations in ICU patient subgroups, but an
extensive evaluation of the prevalence of these alterations is lacking. We present the study design of an international multicenter
observational study to investigate the prevalence of microcirculatory alterations in critically ill: the Microcirculatory Shock
Occurrence in Acutely ill Patients (microSOAP). Methods. 36 ICU’s worldwide have participated in this study aiming for inclusion
of over 500 evaluable patients. To enable communication and data collection, a website, an Open Clinica 3.0 database, and image
uploading software have been designed. A one-session assessment of the sublingual microcirculation using Sidestream Dark Field
imaging and data collection on patient characteristics has been performed in every ICU patient >18 years, regardless of underlying
disease. Statistical analysis will provide insight in the prevalence and severity of sublingual alterations, its relation to systemic
hemodynamic variables, disease, therapy, and outcome. Conclusion. This study will be the largest microcirculation study ever
performed. It is expected that this study will also establish a basis for future studies related to the microcirculation in critically ill.
1.Introduction
The microcirculation plays a pivotal role in oxygen delivery
to the tissue [1]. It is believed to be a key player in several
disease states, such as sepsis and shock. The development
of Orthogonal Polarizing Spectral (OPS) imaging and
more recently Sidestream Dark Field (SDF) imaging has
enabled bedside imaging of the—predominantly sublin-
gual—microcirculation [2, 3]. Main advantage of SDF/OPS
imaging is the ability to visualize true capillary hemodynam-
ics in a noninvasive way at the bedside, thereby providing
functionalinformationrelatedtothemicrocirculationwhere
oxygen delivery to the parenchymal cells takes place. With
SDF/OPS imaging, the presence of microcirculatory alter-
ations in diﬀerent critical care patient subgroups, such as
sepsis, heart failure, and major surgery, has been widely ex-
plored during the past decade [4–9]. These microcirculatory
alterationsappeartobeassociatedwithanadverseprognosis;
they are more severein nonsurvivors in comparison to survi-
vors in sepsis and heart failure, and are associated with the2 Critical Care Research and Practice
development of complications in abdominal surgery [4–12].
The aforementioned studies have all shown that microcircu-
latory alterations are apparent in the presence of more or less
normal systemic haemodynamic parameters, thereby stress-
ing the potential importance of the microcirculation as an
additionaltargetforresuscitation.Severalinterventions,ran-
ging from vasoactive drugs and ﬂuid therapy to circulatory
assist devices, have been shown to have varying eﬀects on
their capacity to inﬂuence microcirculatory failure [7, 13–
22].
Although a randomized controlled clinical trial (RCT) is
considered as the highest level of evidence in medical re-
search, the Empirics already realized the importanceh of
observation for gaining a better understanding of diseases
[23, 24]. Recent literature acknowledges the advantages of
a solid observational study as a powerful tool to include
large patient numbers with a variety of backgrounds, making
the results easier to extrapolate to daily practice as opposed
to RCTs with limited inclusion numbers due to stringent
inclusion and exclusion criteria. This has especially been
advocated for intensive care patients where several large
RCTs fail to demonstrate beneﬁcial eﬀects of interventions.
The heterogeneous nature of patients and applied therapy
as well as uncertain underlying pathophysiology has been
associated with this failure, emphasizing the need for more
observational studies in intensive care patients to gain a
better understanding of both patient characteristics and
eﬀects of interventions [25–29].
In microcirculatory research, the presence and signiﬁ-
canceofmicrocirculatoryfailurehasbeenrepeatedlydemon-
strated in single center studies with a limited number of
patients in a variety ofdiﬀerentICU populations. However, a
solid estimation of the prevalence of microcirculatory alter-
ations in intensive care patients is not available as yet. There-
fore, our aim was to conduct a multicenter observational
study to map the prevalence of microcirculatory alterations
inintensivecarepatients,irrespectiveoftheirunderlyingdis-
ease, to provide a solid basis for further (interventional)
studies. The unique nature of this observational trial will be
that it will not only observe the behavior of conventional
clinical and hemodynamic variables but will also relate these
tothebehaviorofacompletelynewunexploredphysiological
compartment in a multicentral international setting. In this
paper we describe the trial design and methods we propose
of evaluating the data.
2. Methods
Several large multicenter prevalence studies in critical care
settings have been conducted, such as the Sepsis Occurrence
inAcutelyillPatients(SOAP)study,theEuropeanPrevalence
ofInfectioninIntensiveCare(EPIC)studyandtheColumbi-
an internet based Observatorio Nacional de Sepsis Pedi´ atrica
(ONASEP) [30–32]. We aimed for a similar study design.
2.1. Inclusion of Participating Centers. Out of 47 intensive
care units (ICU’s) that were invited to participate in this
study (see Figure 1 for an overview), 36 ICU’s decided to
participate.
The list of participating centers is as follows:
(1) ICU, Medical Center Leeuwarden, Leeuwarden, The
Netherlands
(2) ICU, Antonius Ziekenhuis, Nieuwegein, The Nether-
lands
(3) ICU, Onze Lieve Vrouwe Gasthuis, Amsterdam, The
Netherlands
(4) ICU, Erasmus Medical Center, Rotterdam, The Neth-
erlands
(5) ICU, Gelre Ziekenhuizen, Apeldoorn, The Nether-
lands
(6) Departamento de Medicina Intensiva, Hospital Clin-
ico de la Pontiﬁcia, Universidad Cat´ olica de Chile.
Santiago, Chili
(7) Departamento de Anestesiologia, Dor e terapia In-
tensiva, Hospital Sao Paulo, Universidade Federal de
S˜ ao Paulo, Sao Paulo, Brasil
(8) Servicio de Terapia Intensiva, Sanatorio Otamendi y
Miroli, Buenos Aires, Argentina
(9) ICU, Hospital San Mart´ ın, La Plata, Argentina
(10) ICU, Hospital Espa˜ nol “Juan J Crotoggini,” Montev-
ideo, Uruguay
(11) ICU, Cooper University Hospital, Camden, USA
(12) ICU, Beth Israel Deaconess Medical Center/Harvard
Medical School, Boston, USA
(13) Critical Care Medicine, University of Pittsburgh,
Pittsburgh, PA, USA
(14) Critical Care Medicine, St. John’s Mercy Medical
Center, St Louis, Missouri, USA
(15) ICU, University of California, San Diego, USA
(16) Universit¨ atsklinikum Jena, Friedrich-Schiller-
University, Department of Internal Medicine I,
Jena, Germany
(17) Department of Surgical Intensive Care, University
Hospital Aachen, Aachen, Germany
(18) ICU, Royal London Hospital, London, UK
(19) ICU, Royal Free Hospital, London, UK
(20) ICU, The Royal Marsden Hospital, London, UK
(21) ICU, Derriford Hospital and Nuﬃeld Health Ply-
mouth Hospital, Plymouth, UK
(22) ICU, New Cross Hospital, Wolverhampton, UK
(23) ICU, RDE Hospital, Exeter, UK
(24) Critical Care Department, Joan XXIII University
Hospital, Tarragona, Spain
(25) Department of Intensive Care Medicine, Waikato
Hospital, Hamilton, New ZealandCritical Care Research and Practice 3
Figure 1: Overview of the ICU’s that were invited to participate in
the microSOAP.
(26) ICU, Kaunas University Hospital, Kaunas, Lithuania
(27) Clinica di Anestesia e Rianimazione, Azienda Osped-
aliera-Universitaria Ospedali Riuniti, Ancona, Italy
(28) Dipartimento di Anestesia, Rianimazione e Terapia
Intensiva, Azienda ULSS 9 Veneto, Treviso, Italy
(29) ICU, Santa Maria degli Angeli Hospital, Pordenone,
Italy
(30) ICU, Royal Brisbane and Women’s Hospital, Bris-
bane, Australia
(31) Departement d’Anesthesie-Reanimation, Hopital de
Bicetre, Le Kremlin- Bicˆ e t r e ,P a r i s ,F r a n c e
(32) DepartmentofAnesthesiology,CriticalCareetSamu,
Hˆ opital Lariboisi` ere, Paris, France
(33) ICU, University Hospital Basel, Basel, Switzerland
(34) Faculty of Tropical Medicine, Mahidol University,
Bangkok, Thailand
(35) ICU, Hacettepe University, Ankara, Turkey
(36) ICU, Kosuyolu University, Istanbul, Turkey.
ICU’s were selected based on SDF/OPS availability, estab-
lished skills in OPS/SDF imaging as demonstrated in a sepa-
rate teaching course, and/or publications in this ﬁeld. For
image quality check, centers were asked to provide a repre-
sentative SDF/OPS video of a septic patient and a healthy
volunteer, enabling feedback on image quality. During an
investigators meeting in March 2011, the study was sched-
uled for the second week of September 2011. For logistic
reasons,itwasdecidedthatcenterscouldchoosetwoormore
consecutive days for performing measurements. To prevent
overlapofpatientinclusion,ICU’sweredividedinto(virtual)
units and measured as one unit per day. A medical steering
committee was formed to oversee the study, including repre-
sentatives from the diﬀerent continents as well as the major
centers in the participating countries. The medical steering
consisted of, E. C. Boerma, MD, PhD; N. A. R. Vellinga, MD;
M. Koopmans; A. Donati, MD; A. Dubin, MD, PhD; R. M.
P e a r s e ,M D ,P h D ;N .I .S h a p i r o ,M D ,M P H ;J .B a k k e r ,M D ,
PhD; C. Ince, PhD. The study is coordinated from Medi-
cal Center Leeuwarden by the principal investigator (E. C.
Boerma, MD, PhD), a dedicated physician in charge of run-
ning the communication (N. A. R. Velinga, MD) and a re-
search nurse (M. Koopmans). The study center ensures
communication with and between study centers, coordinates
study logistics, and manages data analysis.
2.2. Patient Selection. Every ICU patient ≥18 years, regard-
less of the underlying disease, was eligible for inclusion. In-
formed consent was obtained in accordance with local ethics
approval. Participation in another study was no exclusion
criterion, except when contradictory to local regulations. Pa-
tients <18 years or without informed consent were excluded,
as well as patients with mucosal bleeding/injury or recent
maxillofacial surgery that interfered with SDF/OPS imaging.
2.3. Ethics Approval. A study protocol was provided to par-
ticipating centers. Every participating center obtained ethics
approval according to local legislation. A copy of the ethics
approval was sent to the study coordinator before start of
the study. Written informed consent was obtained of all
included subjects, unless the local ethics committee specifi-
cally allowed a waiver in this respect.
The study was registered at http://www.clinicaltrials.gov/
(NCT01179243). No (industry) sponsorship has been re-
ceivedforthisinvestigator-initiated study,withtheexception
of a local hospital fund.
2.4. SDF/OPS Imaging. Sublingual OPS and SDF imagings
areusedformicrocirculatoryimaging atthebedside withthe
potential of quantiﬁcation both at the bedside and oﬄine
[33–35]. In short, the OPS and SDF analogue cameras are
incorporated in handheld devices, emitting polarized, re-
spectively, stroboscopic green light, with a wavelength within
the absorption spectrum of haemoglobin, thereby depicting
erythrocytes as black cells. The area of visualization is
approximately 1mm2. These techniques are described in
detail elsewhere [2, 3]. Oﬄine computer assisted analy-
sis yields information on both convection and diﬀusion.
Microvascular ﬂow index (MFI) is calculated to describe
convection in a semiquantitative way; the predominant ﬂow
in all quadrants of the SDF/OPS image is scored for diﬀerent
vessel sizes, using a scale ranging from 0 (no ﬂow) to 3
(continuous ﬂow). The averaged ﬂow score yields the MFI
for each image. MFI has been shown to correlate well
with red blood cell velocity [36]. To obtain information on
diﬀusion, several measures of functional capillary density are
calculated, using a grid dividing the image into 16 segments.
Every vessel crossing the grid is counted; furthermore, for
each vessel crossing the grid, the type of ﬂow using the MFI
scale is used, a ﬂow of 0 (no ﬂow) or 1 (intermittent ﬂow)
is considered as nonperfused, whereas a ﬂow of 2 (sluggish)
or 3 (continuous) describes perfused vessels. By using these
data, several measures of functional capillary density can be
calculated, including proportion of perfused vessels (PPVs)
and perfused vessel density (PVD). Dividing the numbers of4 Critical Care Research and Practice
perfused grid crossings by the total number of grid crossings
yields the PPV; the PVD is calculated as the number of per-
fused grid crossings divided by the total grid length. In the
same way, total vessel density (TVD) can be calculated. A de-
tailed description of MFI and measures of functional capil-
lary density can be found elsewhere [34, 35].
2.5. Data Collection. The sublingual microcirculation was
measured once in every patient. In line with internationally
accepted consensus, 3 to 5 stable sublingual microcirculatory
image sequences of 10–20 seconds were obtained for every
patient [34, 35]. Along with the SDF/OPS imaging, data
on demographics, reason for ICU admission, illness severity
scores, haemodynamics, laboratory values, and treatment
were collected. Afterwards, information on ICU/hospital
length of stay and ICU/hospital mortality will be collected.
2.6. Internet-Based Study Equipment. The speciﬁcations of
the internet platform which has been designed included
(1) compliance with international guidelines on clinical re-
search and data security, (2) fast and reliable uploading of
clinical data and SDF/OPS images, and (3) facilitating
adequate two-way communication. To facilitate commu-
nication, an e-mail server and an open access website
(http://www.microcirculationstudies.org) have been devel-
oped. The website provided general study information and
included a weblog and a frequently asked questions section
to keep participants updated on the latest study news. For
data exchange, a dedicated database has been developed,
based on Open Clinica (OC) 3.1 open source (GNU LPGL
license) clinical trial software [37]. OC is, amongst others,
in compliance with 21 CFR Part 11 (FDA), ICH-GCP and
the US Health Insurance Portability and Accountability Act
of 1996 (HIPAA). It is a Java J2EE-based application that
runs on both Linux and Windows servers. Several other large
multicenter studies have used OC databases, for example,
the European Surgical Outcomes Study (EuSOS) and the
Fluid Expansion As a Supportive Therapy (FEAST) trial
[38, 39]. OC allows customization of its database to meet
study requirements. The electronic CRF is deﬁned using a
special Excel sheet, which is uploaded to the server to deﬁne
the CRF in the database. For the OC database, a dedicated
server is available. Every participating center can log in to a
partofthedatabasethatisassignedtotheirICUtoﬁlloutthe
electronic CRF. After completion of data collection, data will
beexportedtoSPSS18.0,IBM,NewYork,USA,forstatistical
analysis.
A USB stick has been provided to each center with soft-
ware developed speciﬁcally for this study. Its purpose is to
provide the usera ﬁlm editor so that captured ﬁlm fragments
can be edited to identify suitable clips for submission to the
study center in Leeuwarden and to provide the needed com-
munication protocols with the servers. The raw SDF/OPS
image ﬁle can be imported in the image-editing program. By
playing the SDF/OPS video, the user will be able to set a start
markandendmarkattheappropriatepointsoftheSDF/OPS
clip, deﬁning the part of the raw SDF/OPS ﬁle that will be
usedforsubsequentanalysis.Thelimitforthemaximumclip
length is set at 500 frames, that is, 20 seconds. In that way, we
willbeabletolookforthepartoftheclipthatismostsuitable
for analysis. The software on the USB stick automatically
establishes an Internet connection with the central dedicated
microSOAP study server using the required communication
protocol and security settings. Backup copies of the clips are
automatically stored on the USB stick. In case of failure of
Internet connection, the USB stick containing the backup
clips can alternatively be sent to the study coordinator by
regular mail.
2.7. Data Analysis
2.7.1. Sample Size Calculation. Because this is the ﬁrst exten-
sive prevalence study on microcirculatory alterations ever
done, with a primarily explorative character, a concise power
calculationisvirtuallyimpossible.Basedonpreviousstudies,
with a sample size between 25 and 50 patients, in heart
failure, high-risk noncardiac surgery, sepsis, and paediatric
ICU patients, signiﬁcant correlations between the existence
of microcirculatory alterations and parameters of morbidity
and mortality could be established [6, 10, 12]. However, it
is reasonable to assume that morbidity and mortality may
be lower in a general ICU population. Therefore, we aim
for a sample size ten times larger than previously reported
in single-center subgroup studies. Since this is by far the
largestcohortofinvivomicrocirculatoryresearchinhumans
ever done, practical limitations with respect to availability of
SDF/OPS technique and skilled operators will undoubtedly
play a signiﬁcant role in the deﬁnitive sample size.
2.7.2. SDF/OPS Image Analysis. The SDF/OPS image anal-
ysis will be performed by the researchers appointed by the
initiators of this study in accordance with internationally
accepted guidelines using dedicated software [34, 35]. The
analysis will be conducted blinded to the origin of the
ﬁlm clips. In a suitable subgroup, an automatic assessment
method will be performed as described elsewhere to investi-
gate the suitability of such an automatic software for evalua-
tion and quantiﬁcation of microcirculatory alterations [40].
Duetothedemandingimagingtechnique,qualityofSDF
images may vary between centers [41]. However, up-to-date
externally validated image quality scoring systems appear
to be lacking. To ensure consistency in SDF analysis, SDF
analysis will be performed by researchers appointed by the
principal investigators, taking care for ongoing feedback and
aiming for consensus. Since several reports from diﬀerent
research groups have reported excellent inter- and intraob-
server agreement for the SDF image analysis, the steering
committee decided beforehand that this would not be an
extra topic of this study [5, 10, 34].
2.7.3.StatisticalAnalysis. Descriptivestatisticswillbeusedto
describethestudypopulation. Furtherstatisticalanalysiswill
be conducted to relate the microcirculatory alterations to
the severity of disease and other parameters. The primaryCritical Care Research and Practice 5
outcome measure is the prevalence of microcirculatory alter-
ations.Thereisnoconsensusaboutthethresholdsfora“nor-
mal” and an “abnormal” microcirculation. Several research-
e r sh a v er e p o r t e do nv a l u e so fs e v e r a lm i c r o c i r c u l a t o r yv a r -
iables in healthy volunteers; MFI of capillaries (<20µm) is
reported to be 3.0 [2.9–3.0] (median [IQR]), 2.82 (0.1), and
2.97 (0.03) (mean(SD)) (IQR = interquartile range, SD =
standard deviation) [5, 11, 42]. Therefore, one expects 95%
of healthy subjects to have a small vessel MFI between
2.62 and 3 [11]. In healthy volunteers, PPVs (small vessels)
well above 90% are described, whereas in septic patients, a
capillary PPV of 78% (23%) is described [11, 42, 43]. In
septic shock, norepinephrine dose >0.1microgram/kg/min
and a lactate >2mmol/L were associated with a signiﬁcantly
lower PVD (12 [8–15] versus 14 [11–17]n/mm2 for nor-
epinephrine dose >0.1microgram/kg/min and 10 [8–13]
versus 14 [11–17]n/mm2 for lactate >2mmol/L), as well as
a signiﬁcantly lower PPV (80 [70–91] versus 100 [90–100]%
for norepinephrine dose >0.1microgram/kg/min and 82
[71–99] versus93 [84–100]%forlactate>2mmol/L)[44].In
uncomplicated major abdominal surgery, preoperative PPV
(small vessels) was 89% (83–95) versus 79% (73–92) in pa-
tients who developed complications postoperatively [4]. In
this study, ROC curves will be used to ﬁnd cut oﬀ values
of microcirculatory variables in relation to morbidity and
mortality.
Secondary outcome parameters are the correlation
between microcirculatory changes and macrohaemody-
namic variables, correlations between microcirculatory
changes, and length of ICU/hospital stay, mortality, and
SOFA/APACHEIIscores[45,46].Diﬀerencesbetweensever-
alsubgroupswillbeassessedusingat-testincaseofnormally
distributed variables; in case of non-normally distributed
variables, a nonparametric test will be chosen. Whenever
applicable, forward stepwise logistic regression analysis will
be used to test for associations between the severity of
microcirculatory dysfunction and illness severity, mortality,
andlengthofstay.Inaddition,therelationbetweenmicrocir-
culatory alterations, applied therapy (e.g., ﬂuid therapy and
vasopressor therapy), and indicators of peripheral perfusion
(e.g.,lactate)willbeexplored.Furthermore,thegeographical
distribution of microcirculatory alterations will be assessed.
3. Discussion
Thisstudywillbebyfarthelargestcohortofinvivomicrocir-
culationresearch.Weaimtoprovideinsightintheworldwide
prevalence and distribution of microcirculatory alterations.
The questions we hope to answer are the following:
(1) Does the presence of microcirculatory alterations in-
dicate impending bad outcome in terms of morbidity
and mortality?
(2) Does the presence of microcirculatory alterations
provide a more sensitive indicator of morbidity and
mortality then conventional hemodynamic and oxy-
gen derived parameters?
(3) Is the presence of microcirculatory alterations related
to applied therapy, such as ﬂuid therapy and vaso-
pressors?
(4) Is there a diﬀerence between microcirculatory alter-
ations in diﬀerent patient (sub-) groups, and how are
these geographically distributed, as well as over time?
We expect that the results of our study will make clini-
cians more aware of the presence and importance of micro-
circulatory alterations in daily practice, thereby leading to
better identiﬁcation of patients whoare atrisk ofanunfavor-
able outcome. Furthermore, we hope to trigger researchers
to develop methods enabling easier bedside evaluation
of the microcirculation for detection of those at risk of
“microcirculatory failure”, as well as interventions aimed at
ameliorating the microcirculation. Hopefully, by putting the
microcirculation in a central position in future ICU practice,
outcome of critically ill patients will be improved.
4. Conclusion
With an anticipated inclusion rate of approximately 500
patients, this study will provide the largest reported database
of clinical in vivo microscopy in critically ill patients. We
expect that this study will form a solid basis for a deeper
understanding of the prevalence and meaning of microcircu-
latory alterations in intensive care patients and show the way
forward to the design of a goal-directed interventional study
basedonthenormalizationofmicrocirculatoryalterationsin
intensive care patients.
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